3 news items
New MultiCenter Prospective Study Demonstrates Signatera's Clinical Utility in Merkel Cell Carcinoma
NTRA
26 Jul 24
to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
NTRA
3 Jul 24
and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support
Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
NTRA
17 Jun 24
statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially
- Prev
- 1
- Next